These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 180914)

  • 1. Anti-neuraminidase antibody response in hamsters experimentally infected with Sendai virus.
    Profeta ML
    Ann Sclavo; 1975; 17(6):884-92. PubMed ID: 180914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. 1. Sendai virus haemolysis-inhibiting antibodies.
    Orvell C
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):441-50. PubMed ID: 187012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serological tests for detection of antibodies to Sendai virus in rats.
    Rottinghaus AA; Gibson SV; Wagner JE
    Lab Anim Sci; 1986 Oct; 36(5):496-8. PubMed ID: 3022063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between cerulopasmin and Sendai virus envelope components. Note V. Serological response in the rabbit to Sendal virus and subviral fractions.
    Samuel I; Tomas E
    Virologie; 1977; 28(4):277-82. PubMed ID: 203088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities.
    Yewdell J; Gerhard W
    J Immunol; 1982 Jun; 128(6):2670-5. PubMed ID: 6281335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
    Wodal W; Falkner FG; Kerschbaum A; Gaiswinkler C; Fritz R; Kiermayr S; Portsmouth D; Savidis-Dacho H; Coulibaly S; Piskernik C; Hohenadl C; Howard MK; Kistner O; Barrett PN; Kreil TR
    Vaccine; 2012 Jun; 30(31):4625-31. PubMed ID: 22580355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elicitation of anti-viral cytotoxic T lymphocytes with purified viral and H-2 antigens.
    Hale AH; Ruebush MJ; Harris DT
    J Immunol; 1980 Jul; 125(1):428-30. PubMed ID: 6247399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-sensitive virus derived from BHK cells persistently infected with HVJ (Sendai virus).
    Kimura Y; Ito Y; Shimokata K; Nishiyama Y; Nagata I
    J Virol; 1975 Jan; 15(1):55-63. PubMed ID: 163346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. 2. NDV and mumps virus haemolysis-inhibiting antibodies.
    Orvell C
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):451-7. PubMed ID: 998262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites.
    Iorio RM; Bratt MA
    J Immunol; 1984 Oct; 133(4):2215-9. PubMed ID: 6470488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-bound antiviral antibodies as receptors for Sendai virions in receptor-depleted erythrocytes.
    Nussbaum O; Zakai N; Loyter A
    Virology; 1984 Oct; 138(2):185-97. PubMed ID: 6093364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
    Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
    J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of agar-gel precipitin test for the detection of Sendai virus antibody in rat sera.
    Yachida S; Iritani Y; Makino S; Seko S
    Lab Anim Sci; 1975 Aug; 25(4):434-6. PubMed ID: 168429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of enzyme-linked immunosorbent assay, complement fixation, and hemagglutination inhibition serological tests for detection of Sendai virus antibody in laboratory mice.
    Parker JC; O'Beirne AJ; Collins MJ
    J Clin Microbiol; 1979 Mar; 9(3):444-7. PubMed ID: 222802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement fixation, hemagglutination inhibition and neuraminidase inhibition reactions in the seroepidemiologic evaluation of an influenza A epidemic].
    Volpi A; Ragona G; Gentile R; Cervelli G; De Felici A; Muzzi A
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):287-91. PubMed ID: 1016581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of the possible importance of complement in increasing the hemagglutination-inhibiting activity of rabbit IgM against Sendai virus].
    De Stasio A; Orsi N; Seganti L; Sinibaldi L
    Boll Ist Sieroter Milan; 1978 Mar; 57(1):54-9. PubMed ID: 207291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of intranasal vaccination with subunit Sendai virus vaccine in mice.
    Ito H; Matumoto M
    Jpn J Exp Med; 1986 Jun; 56(3):125-9. PubMed ID: 3020282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between ceruloplasmin and Sendai virus envelope components. Note VI. Effect of ceruloplasmin on the antigenicity of Sendai virus and subviral fractions.
    Tomas E; Samuel L
    Virologie; 1978; 29(1):53-7. PubMed ID: 205045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two anti-neuraminidase monoclonal antibodies by complement activation.
    Holmes KT; Hampson AW; Raison RL; Webster RG; O'Sullivan WJ; Mountford CE
    Eur J Immunol; 1982 Jun; 12(6):523-6. PubMed ID: 7117362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.